2018³âµµ ´ëÇѺ´¸®ÇÐȸ °øÅ뿪·®±³À° : 2018-08-25±³À°ÀÏÀÚ : 2018-08-25
±³À°Àå¼Ò : ¼¿ï´ëÇб³ ¾î¸°À̺´¿ø ÀÓ»ó Á¦1°ÀǽÇ
±³À°ÁÖÁ¦ :
2018³âµµ ´ëÇѺ´¸®ÇÐȸ °øÅ뿪·®±³À° ÁÖÃÖ±â°ü : ´ëÇѺ´¸®ÇÐȸ
´ã´çÀÚ : ´ëÇѺ´¸®ÇÐȸ
¿¬¶ôó : 02-795-3094
À̸ÞÀÏ :
kspjamoon@kams.or.kr ±³À°Á¾·ù ; º´¸®°ú
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 6 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 110,000¿ø
ºñ°í 1. ȸ¿ø 1) ¹Ì³³È¸ºñ ¾ø´Â °æ¿ì »çÀüµî·Ï Àü¹®ÀÇ 50,000 ±ºÀÇ°ü30,000 Àü°øÀÇ20,000 ÇöÀåµî·Ï Àü¹®ÀÇ 60,000 ±ºÀÇ°ü40,000 Àü°øÀÇ30,000 2) ¹Ì³³È¸ºñ ÀÖ´Â °æ¿ì »çÀüµî·Ï Àü¹®ÀÇ 70,000 ±ºÀÇ°ü 50,000 Àü°øÀÇ 40,000 ÇöÀåµî·Ï Àü¹®ÀÇ 80,000 ±ºÀÇ°ü 60,000 Àü°øÀÇ 50,000 2. º´¸®ÇÐȸ ȸ¿øÀÌ ¾Æ´Ñ °æ¿ì »çÀüµî·Ï Àü¹®ÀÇ 100,000 À¯°ü¾÷ü ¶Ç´Â ´Üü ¼Ò¼Ó ºñȸ¿ø 100,000 Àü°øÀÇ/Á¶±³/´ëÇпø»ý 50,000 ÇöÀåµî·Ï Àü¹®ÀÇ 110,000 À¯°ü¾÷ü ¶Ç´Â ´Üü ¼Ò¼Ó ºñȸ¿ø 110,000 Àü°øÀÇ/Á¶±³/´ëÇпø»ý 60,000
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 08¿ù 25ÀÏ ¼¿ï´ëÇб³ ¾î¸°À̺´¿ø ÀÓ»ó Á¦1°ÀÇ½Ç 10:00~10:50 NGSÀÇ ±âÃÊ : Before FASTQ ½ÉÈ¿¼·(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 08¿ù 25ÀÏ ¼¿ï´ëÇб³ ¾î¸°À̺´¿ø ÀÓ»ó Á¦1°ÀÇ½Ç 10:50~11:40 NGSÀÇ ±âÃÊ : After FASTQ ÀÌ°èÈ(¼¿ïÀÇ´ë)
Åä·Ð 08¿ù 25ÀÏ ¼¿ï´ëÇб³ ¾î¸°À̺´¿ø ÀÓ»ó Á¦1°ÀÇ½Ç 11:40~12:00 ÁúÀÇ ÀÀ´ä ½ÉÈ¿¼· ÀÌ°èÈ(¿¬¼¼ÀÇ´ë ¼¿ïÀÇ´ë)
±³À°½Ã°£ 08¿ù 25ÀÏ ¼¿ï´ëÇб³ ¾î¸°À̺´¿ø ÀÓ»ó Á¦1°ÀÇ½Ç 13:00~13:40 NGS °Ë»ç½ÇÀÇ ¿î¿µ°ú Guideline ¹èÁ¤¸ð(¼¿ïÀÇ´ë)
±³À°½Ã°£ 08¿ù 25ÀÏ ¼¿ï´ëÇб³ ¾î¸°À̺´¿ø ÀÓ»ó Á¦1°ÀÇ½Ç 13:40~14:10 NGS Report ¼ºÃ¢¿Á(¿ï»êÀÇ´ë)
±³À°½Ã°£ 08¿ù 25ÀÏ ¼¿ï´ëÇб³ ¾î¸°À̺´¿ø ÀÓ»ó Á¦1°ÀÇ½Ç 14:10~14:40 Knowledge-Based Analysis ¹ÚÇÏ¿µ(ÀÎÁ¦ÀÇ´ë)
Åä·Ð 08¿ù 25ÀÏ ¼¿ï´ëÇб³ ¾î¸°À̺´¿ø ÀÓ»ó Á¦1°ÀÇ½Ç 14:40~15:00 ÁúÀÇ ÀÀ´ä ¼ºÃ¢¿Á ¹ÚÇÏ¿µ(¿ï»êÀÇ´ë ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 08¿ù 25ÀÏ ¼¿ï´ëÇб³º´¿ø ¾î¸°À̺´¿ø ÀÓ»ó Á¦1°ÀÇ½Ç 15:00~15:30 NGS Case Study (I) À̾ƿø(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 08¿ù 25ÀÏ ¼¿ï´ëÇб³ ¾î¸°À̺´¿ø ÀÓ»ó Á¦1°ÀÇ½Ç 15:30~16:00 NGS Case Study (II) ±èÁöÈÆ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 08¿ù 25ÀÏ ¼¿ï´ëÇб³ ¾î¸°À̺´¿ø ÀÓ»ó Á¦1°ÀÇ½Ç 16:00~16:50 Beyond Current Application of Clinical NGS ±èŹÎ(°¡Å縯´ë ÀÇ·áÁ¤º¸Çб³½Ç)
Åä·Ð 08¿ù 25ÀÏ ¼¿ï´ëÇб³ ¾î¸°À̺´¿ø ÀÓ»ó Á¦1°ÀÇ½Ç 16:50~17:00 ÁúÀÇ ÀÀ´ä À̾ƿø±èÁöÈƱèŹÎ(°¡Å縯ÀÇ´ë¿ï»êÀÇ´ë°¡Å縯´ë ÀÇ·áÁ¤º¸Çб³½Ç)